Events

Barcelona, Spain. ORYZON announced today that it will be presenting at the 2nd European Cancer Cluster Meeting (ECCP 2010). to be held in gather in Oslo, Norway, September 15-17

Europe’s most promising oncology biotechs and other key stakeholders will gather in Oslo, Norway, September 15-17 for the 2nd European Cancer Cluster Meeting (ECCP 2010). Co-hosted by the Oslo Cancer Cluster and the Cancer-Bio-Santé Cluster from Toulouse, the two-day meeting is a unique partnering opportunity for oncology biotech companies, business development and licensing executives from the pharmaceutical industry and investors, as well as innovative researchers and clinicians. Oryzon will present the progresses of our drug discovery program in EPIGENETIC targets for oncological disorders and also the progresses of our Diagnostic Program with the advances of our product to detect early and in a non invasive way endometrial cancer from uterine aspirates.